Nucleic acid therapies: Towards cardiac-specific recombinant adeno-associated viruses (rAAVs) of human origin: Directed evolution and characterization of novel AAV variants isolated from human failing hearts in models with human relevance and relevance fo
- Förderkennzeichen
81X2710183
- Projektnummer
1315
- Institution
- Universitätsklinikum Hamburg-Eppendorf (UKE)
- Projektleiter
- Arne Hansen
- Standort
- Hamburg/Kiel/Lübeck
- Projektart
- Innovation Cluster
- Fördersumme
- € 206.542,00
- Beginn
- 01.01.2021
- Ende
- 31.12.2024
- Partnerprojekte